Oculis (NASDAQ:OCS) Earns Buy Rating from Chardan Capital
Chardan Capital reissued their buy rating on shares of Oculis (NASDAQ:OCS – Free Report) in a report issued on Tuesday, Benzinga reports. Chardan Capital currently has a $30.00 price target on the stock. Several other analysts have also recently weighed in on OCS. Robert W. Baird boosted their price target on Oculis from $35.00 to […]
More Stories
Canada to Start Retaliatory Tariffs on US Goods Beginning Sept. 8
By Jacki Thrapp Canadian Prime Minister Mark Carney announced on Saturday that retaliatory tariffs on U.S. goods will take effect...
Judge Strikes Down Trump Admin Policy Suspending Visa Processing From 75 Countries
By Jacki Thrapp A federal judge struck down a Trump administration policy that suspended the issuance of immigrant visas for...
SBA Proposes Changes to Benefit Over 110,000 Businesses
By Naveen Athrappully The U.S. Small Business Administration (SBA) is proposing an overhaul of business size standards, a move that...
Wall Street Review: Stocks Post Weekly Loss Despite Friday Gains
By Panos Mourdoukoutas U.S. stocks ended Friday in the green but posted a weekly loss as rising bond yields weighed...
How to Activate Funimation Account? Cancellation Process, Alternatives, and Comparison
Are you also looking for an answer to your question about how to activate Funimation and related queries, like the...
Netflix’s Upcoming Adult Animated Series, Dang! Release Date, Trailer, Plot, and More
Are you ready to meet the most chaotic siblings on Netflix? The upcoming adult animated series, Dang!, is coming soon....